author-photo

Michael R. Charlton

Mayo Clinic
Intermountain Medical Center
University of Chicago

336

Papers

25325

Citations

Citation Trend

Filter By

Papers (237) Sort By

Journal Conference Others

LBP-03-LPCN 1144, an Androgen Receptor Agonist Targeted for NASH, Reduces Liver Fat and Key Serum Biomarkers

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)‐Viremic Donors Into HCV‐Negative Recipients: Outcomes Following Liver Transplant of HCV‐Viremic Donors

2019 Hepatology
Show All
- Source
- Cite
- Save
Citations (58)
The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality From Cirrhosis

2019 Hepatology
- Thomas G. Cotter
- Michael R. Charlton
Show All
- Source
- Cite
- Save
Citations (7)
Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct‐Acting Antiviral Era

2019 Liver Transplantation
Show All
- Source
- Cite
- Save
Citations (36)
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (97)
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection

2018 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (67)
The association of circulating microRNAs (miRs) with liver fibrosis stage and the impact of selonsertib treatment in patients with NASH

2018 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (1)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

2018 Hepatology
Show All
- Source
- Cite
- Save
Citations (2687)
Responsiveness of controlled attenuation parameter (CAP) and its correlation with magnetic resonance imaging-proton density fat fraction (MRI-PDFF) in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)

2018 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis

2018
Show All
- Source
- Cite
- Save
Citations (3)